Extracellular matrix, growth factors and their interactions in the pathogenesis of diabetic kidney disease

Nephrology

Volumn 2, Issue 5, 1996, Pages 291-303

  Gilbert, Richard E ^a   Cooper, Mark E ^a   Jerums, George ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

Extracellular matrix; Gene regulation; Growth factors; mRNA; Nephropathy; Transforming growth factor

Indexed keywords

EID: 0009467853     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1996.tb00105.x     Document Type: Review

References (133)

1. Kimmelstiel P, Wilson C. Intercapillary lesions in the glomerulus. Am. J. Pathol 1936; 12: 83-97.
2. Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC. Structural-functional relationships in diabetic nephropathy. J. Clin. Invest. 1984; 74: 1143-55.
3. Østerby R, Grundersen HJG. Fast accumulation of basement membrane material and the rate of morphological changes in acute experimental diabetic glomerular hypertrophy. Diabetologia 1980; 18: 493-500.
4. Williamson JR, Tilton RG, Chang K, Kilo C. Basement membrane abnormalities in diabetes mellitus: relationship to clinical microangiopathy. Diabetes Metab. Rev. 1988; 4: 339-70.
5. Reichardt LF. Extracellular matrix molecules and their receptors. In: Kreis T, Vale R (eds). Guidebook to the extracellular matrix and adhesion proteins. Oxford University Press, Oxford, 1993.
6. Lin CQ, Bissell MJ. Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J. 1993; 7: 737-43.
7. Stoker AW, Streuli CH, Martins-Green M, Bissell MJ. Designer microenvironment for the analysis of cell and tissue function. Curr. Opin. Cell Biol. 1990; 2: 864-74.
8. Bissell DM, Caron JM, Babiss LE, Friedman JM. Transcriptional regulation of the albumin gene in cultured rat hepatocytes. Mol. Biol. Med. 1990; 7: 187-97.
9. Mattana J, Singhal PC. Applied pressure modulates mesangial cell proliferation and matrix synthesis. Am. J. Hypertens. 1995; 8: 1112-20.
10. Clarke MSF, Feeback DL. Mechanical load induces sarcoplasmic wounding and FGF release in differentiated human skeletal muscle cultures. FASEB J. 1996; 10: 502-9.
11. Wilson E, Sudhir K, Ives H. Mechanical strain of rat vascular smooth muscle cells is sensed by specific extracellular matrix integrin interacrion. J. Clin. Invest. 1995; 96: 2364-72.
12. Border WA, Okuda S, Nakamura T. Extracellular matrix and glomerular disease. Semin. Neph. 1989; 9: 307-31.
13. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. The extracellular matrix. In: Molecular Biology of the Cell. Garland Publishing, New York, 1989; 802-823.
14. Ayo SH, Rodnik RA, Garoni JA, Glass II WF, Kreiberg JI. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am. J. Pathol. 1990; 136: 1339-48.
15. Ayo SH, Radnik RA, Glass II WF et al. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am. J. Physiol. 1991; 260: F185-91.
16. Ayo SH, Radnik RA, Glass II WF, Garoni JA, Troyer DA, Kreisberg JI. High glucose increases diacylglycerol mass and activated protein kinase C in mesangial cell cultures. Am. J. Physiol. 1991; 261: F647-56.
17. Kreisberg JI, Kreisberg SH. High glucose activates protein kinase C and stimulates fibronectin gene expression by enhancing a cAMP response element. Kidney Int. 1995; 48: S3-11.
18. Cagliero E, Maiello EM, Boeri D, Roy S, Lorenzi M. Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J. Clin. Invest. 1988; 82: 735-8.
19. Cagliero E, Roth T, Roy S, Lorenzi M. Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes 1991; 40: 102-10.
20. Roy S, Sala R, Cagliero E, Lorenzi M. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc. Natl Acad. Sci. USA 1990; 87: 404-8.
21. Viberti GC, Bilous RW, Mackintosh D, Bending JJ, Keen H. Longterm correction of hyperglycaemia and progression of renal failure in insulin-dependent diabetes. BMJ 1983; 286: 598-602.
22. Striker LJ, Doi T, Elliot S, Striker GE. The contribution of glomerular mesangial cells to progressive glomerulosclerosis. Semin. Nephrol. 1989; 9: 318-28.
23. Getman WF, DiMari SJ, Hoover RL, Jacobson HR, Haralson MA. Control of mesangial cell growth and collagen production by extracellular matrix. J. Am. Soc. Nephrol. 1991; 2: 574 (abstract).
24. Birchall IE, Chen YP, Kincaid-Smith P, Becker GE. Extracellular matrix components in Kimmelstiel Wilson nodules. Nephrology 1995; 1: 291-5.
25. Poulsom R, Kurkinen M, Prockop DJ, Boot-Handford RP. Increased steady-state levels of laminin B1 mRNA in kidneys of long-term streptozotocin-diabetic rats. J. Biol. Chem. 1988; 263: 10 072-6.
26. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H. ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 1992; 41: 1520-7.
27. Ihm C-G, Lee GSL, Nast CC et al. Early increased renal procollagen α1(IV) mRNA levels in streptozotocin induced diabetes. Kidney Int. 1992; 41: 768-77.
28. Ledbetter S, Copeland EJ, Noonan D, Vogeli G, Hassell JR. Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Diabetes 1990; 39: 196-203.
29. Beisswenger PJ, Spiro RG. Studies on the human glomerular basement membrane. Composition, nature of the carbohydrate units and chemical changes in diabetes mellitus. Diabetes 1973; 22: 180-93.
30. Klein L, Butcher DL, Sudilovsky O, Kikkawa R, Miller M. Quantification of collagen in renal glomeruli isolated from human non-diabetic and diabetic kidneys. Diabetes 1975; 24: 1057-65.
31. Wahl P, Deppermann D, Hasslacher C. Biochemistry of glomerular basement membrane of the normal and diabetic human. Kidney Int. 1982; 21: 744-9.
32. Falk RJ, Scheinman JI, Mauer SM, Michael AF. Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 1983; 32 (Suppl. 3): 24-39.
33. Shimomura H, Spiro RG. Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes. Diabetes 1987; 36: 374-81.
34. Tamsma JT, van den Born J, Bruijn JA et al. Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 1994; 37: 313-20.
35. Striker GE, He C-J, Liu Z-H et al. Pathogenesis of nonimmune glomerulosclerosis: studies in animals and potential applications to humans. Lab. Invest. 1995; 73: 596-605.
36. Kleppel MM, Fan WW, Cheong HI, Michael A. Evidence for separate networks of classical and novel basement membrane collagen. J. Biol. Chem. 1992; 267: 4137-42.
37. Nerlich A, Schleicher E. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am. J. Pathol. 1991; 139: 889-99.
38. Nerlich AG, Schleicher ED, Wiest I, Specks U, Timpl R. Immunohistochemical localization of collagen VI in diabetic glomeruli. Kidney Int. 1994; 45: 1648-56.
39. Glick AD, Jacobson HR, Haralson MA. Mesangial deposition of type I collagen in human glomerulosclerosis. Human Pathol. 1992; 23: 1373-9.
40. Bruneval P, Foidart JM, Nochy D, Camilleri JP, Bariety J. Glomerular matrix proteins in nodular glomerulosclerosis in association with light chain disease and diabetes mellitus. Human Pathol. 1985; 16: 477-84.
41. Striker LM, Killen PD, Chi E, Striker GE. The composition of glomerulosclerosis. 1. Studies in focal sclerosis, crescentic glomerulonephritis and membranoproliferative glomerulonephritis. Lab. Invest. 1984; 51: 181-92.
42. Lan HY, Nicolic-Paterson DJ, Atkins RC. Involvement of activated periglomerular leucocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis. Lab. Invest. 1992; 67: 743-51.
43. Nagase H. Matrix metalloproteinases: a mini-review. In: Koide H, Hayashi T (eds). Extracellular matrix in the Kidney. Contrib. Nephrol. Basel Karger, 1994; 85-93.
44. Kitamura M, Kitamura A, Mitarai T et al. Gene expression of metalloproteinase and its inhibition in mesangial cells exposed to high glucose. Biochem. Bi. Phys. Commun. 1992; 185: 1055-61.
45. McLennan SV, Fisher EJ, Yue DK, Turtle JR. High glucose concentration causes a decrease in mesangium degradation. Diabetes 1994; 43: 1041-5.
46. Schaefer L, Schaefer RM, Ling H, Teschner M, Heidland A. Renal proteinases and kidney hypertrophy in experimental diabetes. Diabetologia 1994; 37: 567-71.
47. Schechter P, Boner G, Rabkin R. Tubular cell protein degradarion in early diabetic renal hypertrophy. J. Am. Soc. Nephrol. 1994; 4: 1582-7.
48. Nakamura T, Fukui M, Ebihara I, Osada S, Tomino Y, Koide H. Abnormal gene expression of matrix metalloproteinases and their inhibitor in glomeruli from diabetic rats. Renal Physiol. Biochem. 1994; 17: 316-25.
49. Abboud HE. Growth factors in glomerulonephritis. Kidney Int. 1993; 43: 252-67.
50. Bruijn JA, Roos A, DeGeus B, DeHeer E. Transforming growth factor-β and the glomerular extracellular matrix in renal pathology. J. Lab. Clin. Med. 1994; 123: 34-47.
51. Mann GB, Fowler KJ, Gabriel A, Nice EC, Williams RL, Dunn AR. Mice with null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 1993; 73: 249-61.
52. Nakamura T, Ebihara I, Tomino Y, Koide H, Kicuchi K, Koiso K. Gene expression of growth related proteins and ECM constituents in response to unilateral nephrectomy. Am. J. Physiol. 1992; 262: F389-96.
53. Kreisberg JI, Radnik RA, Ayo SH, Garoni J, Saikumar P. High glucose elevates c-fos and c-jun transcripts and proteins in mesangial cell cultures. Kidney Int. 1994; 46: 105-12.
54. Wolf G, Sharma K, Ericksen M, Ziyadeh FN. High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int. 1992; 46: 647-56.
55. Shankland SJ, Scholey JW, Ly H, Thai K. Expression of growth-related proto-oncogenes during diabetic renal hypertrophy. Kidney Int. 1995; 47: 782-8.
56. Rasch R, Norgaard JOR. Renal enlargement: comparative autoradiographic studies of 3H-thymidine uptake in diabetic and uninephrectomised rats. Diabetologia 1983; 25: 280-7.
57. Rasch R, Nyengaard J, Flyvberg A. The number of nuclei in glomeruli from diabetic rats. Proceedings of European Diabetic Nephropathy Study Group. Heidelberg, 1995 (abstract).
58. Schwieger J, Fine LJ. Renal hypertrophy, growth factors, and nephropathy in diabetes mellitus. Semin. Nephrol. 1990; 10: 242-53.
59. Bortz JD, Rotwein P, DeVol D, Bechtel PJ, Hansen VA, Hammerman MR. Focal expression of insulin-like growth factor in rat kidney collecting duct. J. Cell. Biol. 1988; 107: 811-19.
60. Arnqvist HJ, Ballerman BJ, King GL. Receptors for and effects of insulin and IGF-I in rat glomerular cells. Am. J. Physiol. 1988; 254: C411-16.
61. Bach LA, Jerums G. Effect of puberty on initial kidney growth and rise in kidney IGF-I in diabetic rats. Diabetes 1990; 39: 557-62.
62. Flyvberg A, Thorlacius-Ussing O, Naerra R, Ingerslev J, Orskov H. Kidney tissue sometomedin C and initial renal growth in diabetic and uninephrectomised rats. Diabetologia 1988; 31: 310-31.
63. Nakamura T, Fukui M, Ebihara I et al. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 1993; 42: 450-6.
64. Landau D, Chin E, Flyvberg A, Roberts CT, Bondy C, LeRoith D. Experimental diabetes mellitus (DM) induces region specific changes in renal IGF system. J. Am. Soc. Nephrol. 5: 696 (abstract).
65. Ortiz-Caro J, Gonzalez C, Jolin T. Diurnal variations of plasma growth hormone, thyrotrophin, thyroxine, and triiodothyronine in streptozotocin-diabetic and food-restricted rats. Endocrinology 1984; 115: 2227-32.
66. Creely JJ, DiMari SJ, Howe AM, Hyde CP, Haralson MA. Effect of epidermal growth factor on collagen synthesis by an epithelioid cell line derived from normal rat kidney. Am. J. Pathol. 1990; 136: 1247-57.
67. Kanda S, Nomata K, Saha PK et al. Growth factor regulation of renal cortical tubular cells by epidermal growth factor, insulin-like growth factor I, acidic and basic fibroblast growth factors and transforming growth factor-β in serum free culture. Cell. Biol. Int. 1989; 13: 687.
68. Salido EC, Yen PH, Shapiro LJ, Fisher DA, Barajas L. In situ hybridization of prepro-epidermal growth factor mRNA in the mouse kidney. Am. J. Physiol. 1989; 256: F632-38.
69. Kanda S, Saha PK, Nomata K et al. Transient increase in renal epidermal growth factor content after unilateral nephrectomy in the mouse. Acta Endocrinol. 1991; 124: 188-93.
70. Miller SB, Rogers SA, Estes CE, Hammerman MR. Increased distal nephron EGF content and altered distribution of peptide in compensatory renal hypertrophy. Am. J. Physiol. 1992; 262: F1032-8.
71. Kanda S, Igawa T, Sakai H, Nomata K, Kanetake H, Saito Y. Anti-epidermal growth factor antibody inhibits compensatory renal hyperplasia but not hypertrophy after unilateral nephrectomy in mice. Biochem. Biophys. Res. Commun. 1992; 187: 1015-21.
72. Dagoga-Jack S, Marshall SM, Kendall-Taylor P, Alberti KG. Urinary excretion of human epidermal growth factor in the various stages of diabetic nephropathy. Clin. Endocrinol. 1989; 31: 167-73.
73. Thompson NL, Flanders KC, Smith JM, Ellingsworth LR, Roberts AB, Sporn MB. Expression of transforming growth factor-β1 in specific cells and tissues of adult and neonatal mice. J. Cell Biol. 1989; 108: 661-9.
74. MacKay K, Kondiah P, Danielpour D, Ausin III HA, Brown PD. Expression of transforming growth factor-β1 and β2 in rat glomeruli. Kidney Int. 1990; 38: 1095-100.
75. Bodi I, Kimmel PL, Abraham AA, Sporn MB, Klotman PE, Kopp JB. Increased TGF-β expression in HIV-associated nephropathy. J. Am. Soc. Nephrol. 1993; 4: 461 (abstract).
76. Yamamoto T, Nakamura T, Noble NA, Ruoslathi E, Border WA. Expression of transforming growth factor-β is elevated in human and experimental diabetic nephropathy. Proc. Natl Acad. Sci. USA; 1993; 90: 1814-18.
77. Sharma K, Ziyadeh FN. The emerging role of transforming growth factor-β in kidney diseases. Am. J. Physiol. 1994; 35: F829-42.
78. MacKay K, Striker LJ, Stauffer JW, Doi T, Agodoa LY, Striker GE. Transforming growth factor-β. Murine glomerular receptors and responses in isolated glomerular cells. J. Clin. invest. 1989; 83: 1160-67.
79. Marti HP, Lee L, Kashgarian M, Lovett DH. Transforming growth factor-β1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. Am J. Pathol. 1994; 144: 82-94.
80. Borsi L, Castellani P, Risso AM, Leprini A, Zardi L. Transforming growth factor-beta regulates the splicing pattern of fibronectin messenger RNA precursors. FEBS Lett. 1990; 261: 175-8.
81. Border WA, Noble NA, Yamamoto T, Tomooka S, Kagami S. Antagonists of transforming growth factor-β: A novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis. Kidney Int. 1992; 41: 566-70.
82. Skonier J, Neubauer M, Madisen L, Bennett K, Plowman GD, Purchio AF. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a humanadenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol. 1992; 11: 511-22.
83. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslathi E. Suppression of experimental glomerulonephritis by anti-serum against transforming growth factor beta-1. Nature 1990; 346: 371-4.
84. Border WA, Noble N, Yamamoto T et al. Natural inhibitor of transforming growth factor-β protects against scarring in experimental disease. Nature 1992; 360: 361-4.
85. Isaka Y, Fuijiwara Y, Ueda N, Kaneda T, Kamada T, Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J. Clin. Invest. 1993; 92: 2597-601.
86. Edwards DR, Murphy G, Reynolds JJ et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 1987; 6: 1899-1904.
87. Ignotz RA, Endo T, Massagué J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β. J. Biol. Chem. 1987; 262: 6443-6.
88. Pettinen RP, Kobayashi S, Bornstein P. Transforming growth factor-β increases mRNA for matrix proteins both in the presence and absence of changes in mRNA stability. Proc. Natl Acad. Sci. USA 1988; 85: 1105-8.
89. Rocco MV, Chen Y, Goldfarb S et al. Elevated glucose stimulates TGF-β gene expression and bioactivity in proxila tubule. Kidney Int. 1992; 41: 107-14.
90. Cagliero E, Maiello M, Boeri D, Lorenzi M. High glucose increases transforming growth factor beta (TGF-β) mRNA in endothelial cells: a mechanism for the latered regulation of basement membrane components? Diabetes 1988; 37 (Suppl. 1): 97A.
91. Ladson-Wofford S, Riser BL, Cortes P. High extracellular glucose concentrations increase receptors for transforming growth factor-β (TGF-β) in rat mesangial cells in culture. J. Am. Soc. Nephrol. 1994; 5: 696 (abstract).
92. Cagliero E, Maiello EM, Boeri D, Roy S, Lorenzi M. Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J. Clin. Invest. 1988; 82: 735-8.
93. Rollineni JS, Reddi AS. Transforming growth factor-β1 enhances glomerular collagen synthesis in diabetic rats. Diabetes 1993; 42: 1673-7.
94. Shankland SJ, Scholey JW. Expression of receptor subtypes for transforming growth factor-β in normal and diabetic rat glomeruli. J. Am. Soc. Nephrol. 1994; 5: 972 (abstract).
95. Cagliero E, Roth T, Taylor AW, Lorenzi M. The effects of high glucose on human endothelial cell growth and gene expression are not mediated by transforming growth factor-β. Lab. Invest. 1995; 73: 667-73.
96. Sharma K, Ziyadeh FN. Renal hypertrophy is associated with upregulation of TGF-β1 gene expression in diabetic BB rat and NOD mouse. Am. J. Physiol. 1994; 267: F1094-101.
97. Shankland SJ, Scholey JW, Ly H, Thai K. Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int. 1994; 46: 430-42.
98. Pankewycz OG, Guan J-X, Bolton WK, Gomez A, Benedict JF. Renal TGF-β regulation in spontaneously diabetic NOD mice with correlations in mesangial cells. Kidney Int. 1994; 294: 1443-7.
99. Sharma K, Lin Y, Guo J, Ziyadeh FN. Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996; 45: 522-30.
100. Young BA, Johnson RJ, Alpers CE et al. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int. 1995; 47: 935-44.
101. Iwano M, Kubo A, Nishino T et al. Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus. Kidney Int. 1996; 49: 1120-6.
102. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc. Natl Acad. Sci. USA 1992; 89: 2873-7.
103. Inaba T, Ishibashi S, Gotoda T et al. Enhanced expression of platelet-derived growth factor-β receptor in high glucose. Diabetes 1996; 45: 507-12.
104. Gesualdo L, Piazani M, Floriano JJ et al. Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab. Invest. 1991; 65: 160-7.
105. Iida H, Seifert R, Alpers CE et al. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial cell proliferative glomerulonephritis. Proc. Natl Acad. Sci. USA 1991; 88: 6560-4.
106. Canton AD. Adhesion molecules in renal disease. Kidney Int. 1995; 48: 1687-96.
107. Chen Q, Kinch MS, Lin TH, Burridge K, Juliano RL. Integrin-mediated cell adhesion activates mitogen-activated protein kinases. J. Biol. Chem. 1994; 269: 26602-5.
108. Ihm C, Park J, Ahn J, Lee T, Cho B, Kim M. Effect of glucose and cytokines on the expression of cell adhesion molecules on mesangial cells. Kidney Int. 1995; 48: S39-42.
109. Roth T, Podesta F, Stepp MA, Boeri D, Lorenzi M. Integrin overexpression induced by high glucose and by human diabetes: Potential pathway to cell dysfunction in diabetic microangiopathy. Proc. Natl Acad. Sci. USA 1993; 90: 9640-4.
110. Sage EH, Borinstein P. Extracellular proteins that modulate cell-matrix interactions. SPARC, tinascin and thrombospondin. J. Biol. Chem. 1991; 266: 14831-4.
111. Gilbert RE, Paul G McNally, Alison Cox et al. SPARC Gene expression is Reduced in Early Diabetes Related Kidney Growth. Kidney Int. 1995; 48: 1216-25.
112. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by phracological amelioration of glomerular capillary hypertension. J. Clin. Invest. 1986; 77: 1925-30.
113. Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth facror-β expression in rat glomerular mesangial cells. J. Clin. Invest. 1994; 93: 2431-7.
114. Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteric obstruction. Kidney Int. 1995; 47: 1285-94.
115. Ruiz-Ortega M, Gonzalez S, Serón D et al. ACE inhibirion reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int. 1995; 48: 1778-91.
116. Nakamura T, Takahashi T, Fukui M, Ebihara I, Osada S, Tomino Y, Koide H. Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats. J. Am. Soc. Nephrol. 1995; 5: 1492-7.
117. Fukui M, Nakamura T, Ebihara I et al. Effects of enalapril on endothelin-1 and growth factor gene expression in diabetic rat glomeruli. J. Lab. Clin. Med. 1994; 123: 763-8.
118. Floege J, Eng E, Young BA, Couser WG, Johnson RJ. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int. 1993; 43: 369-80.
119. Diamond JR, Karnovsky MJ. Nonanticoagulant protective effect of heparin in chronic minonucleoside nephrosis. Renal Physiol. 1986; 9: 366-74.
120. Gambaro G, Carazzano AO, Luzi P et al. Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int. 1992; 42: 1285-91.
121. Ceol M, Nerlich A, Baggio B et al. Increased glomerular α1(IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment. Lab. Invest. 1996; 74: 484-95.
122. Dominiczak MH. The significance of the products of the Maillard (browning) reaction in diabetes. Diab. Med. 1991; 8: 505-16.
123. Anderson SS, Kim Y, Tsilibary EC. Effects of matrix glycation on mesangial cell adhesion, spreading and proliferation. Kidney Int. 1994; 46: 1359-67.
124. Soulis T, Cooper ME, Vranes D, Bucala R, Jerums G. Effect on aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment. Kidney Int. 1996; 50: 627-34.
125. Yang C-W, Vlassara H, Peten EP, He C-J, Striker GE, Striker LJ. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc. Natl Acad. Sci. USA 1994; 91: 9346-440.
126. Cohen MP, Ziyadeh FN. Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy. J. Am. Soc. Nephrol. 1996; 7: 183-90.
127. Cohen MP, Sharma K, Jin Y et al. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. J. Clin. Invest. 1995; 95: 2338-45.
128. Vincent TS, Wulfert E, Merler E. Inhibition of growth factor signaling pathways by lovastatin. Biochem. Biophys. Res. Commun. 1991; 180: 1284-9.
129. O'Donnell MP, Kasiske BL, Kim Y, Atluru D, Keane WF. Lovastatin inhibits proliferation of rat mesangial cells. J. Clin. Invest. 1993; 91: 83-7.
130. Grandaliano G, Biswas P, Choudhury GG, Ahhoud HE. Simvastain inhibits PDGF-induced DNA syntheis in human glomerular mesangial cells. Kidney Int. 1993; 44: 503-8.
131. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990; 343: 425-30.
132. Han DC, Kim JH, Cha MK, Song KI, Hwang SD, Lee HB. Effect of HMGCoA reductase inhibition on TGF-β1 mRNA expression in diabetic rat glomeruli. Kidney Int. 1995; 48 (Suppl. 51 ): S61-5.
133. Nakamura T, Ebihara I, Fukui M, Tomino Y, Koide H. Effect of specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli. Diabetes 1995; 44: 895-9.